Title : Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.

Pub. Date : 2008 Apr 25

PMID : 17434617






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: This post-marketing surveillance registry is aimed at determining the safety and reliability of the CYPHER Select Sirolimus-eluting stent (SES) in routine clinical practice. ses LIM domain binding 3 Homo sapiens
2 BACKGROUND: Little information and angiographic follow-up data in large-scale "real world" registry is available for the CYPHER Select SES, an advanced-generation SES. ses LIM domain binding 3 Homo sapiens
3 BACKGROUND: Little information and angiographic follow-up data in large-scale "real world" registry is available for the CYPHER Select SES, an advanced-generation SES. ses LIM domain binding 3 Homo sapiens
4 Angiographic follow-up at 9 months was performed in 418 (68.3%) lesions treated by CYPHER Select SES. ses LIM domain binding 3 Homo sapiens
5 The safety and efficacy of CYPHER Select SES shown in this registry are consistent with those seen in SES studies. ses LIM domain binding 3 Homo sapiens